LCC [Liverpool ChiroChem] logo

LCC [Liverpool ChiroChem]

Chemistry platform built on proprietary chiral chemical space, progressing hits to small molecule lead candidate assets.

30 employees · est. 2014 · Liverpool, United Kingdom

VS
Protagonist Therapeutics logo

Protagonist Therapeutics

Develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies

156 employees · est. 2006 · Newark, United States

Protagonist Therapeutics is the older company (2014 vs 2006); Protagonist Therapeutics is the larger of the two.

Side-by-Side Comparison

LCC [Liverpool ChiroChem] Protagonist Therapeutics
Founded
2014 2006 older
Headquarters
Liverpool, United Kingdom Newark, United States
Employees
30 156 larger
Industry
Biotechnology, Health Care, Manufacturing Biotechnology, Health Care
Funding Stage
Series Unknown IPO
Total Funding
$5.75M $537.50M
Funding Rounds
4 12
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Chiral Chemistry, Drug Discovery, Chemical Space, Chemical Library, CRO Services, Biotech/Pharmaceutical R&D, Small Molecule Lead Candidates, Chiral Technology, Chemical Building Blocks, Fragment-Based Drug Discovery (FBDD), Virtual Library, Chemical Synthesis, Therapeutic Areas, Asymmetric Hydrogenation, Pd-Coupling Not tracked yet
Website
liverpoolchirochem.com protagonist-inc.com
LCC [Liverpool ChiroChem] logo

About LCC [Liverpool ChiroChem]

LCC [Liverpool ChiroChem] is a biotechnology startup leveraging its proprietary chiral chemistry platform to advance small molecule lead candidate assets for the treatment of oncology and rare diseases. Established in 2014, LCC has successfully developed its PACE platform, focusing on component qual...

Protagonist Therapeutics logo

About Protagonist Therapeutics

Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical n...

We will tell you when either one moves

BounceWatch watches LCC [Liverpool ChiroChem] and Protagonist Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at LCC [Liverpool ChiroCh... and Protagonist Therapeuti... — by email.

Frequently Asked Questions

LCC [Liverpool ChiroChem] — Chemistry platform built on proprietary chiral chemical space, progressing hits to small molecule lead candidate assets.. Protagonist Therapeutics — Develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
LCC [Liverpool ChiroChem] has raised $5.75M while Protagonist Therapeutics has raised $537.50M.
LCC [Liverpool ChiroChem] and Protagonist Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare LCC [Liverpool ChiroChem] with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at LCC [Liverpool ChiroChem] on 6 Dec 2024, and Protagonist Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes